Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Celltrion Inc (068270 KS)
Watchlist
694
Analysis
Health Care
•
South Korea
Celltrion Inc. produces and sells biosimilar products and also provides consignm ent processing service for other companies. The Company's main product is Abata cept which is for arthritis treatment
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Celltrion Inc
•
08 Jan 2026 08:05
•
Broker
Celltrion (068270 KS/Buy)Consensus Miss Unlikely to Be Repeated This Year
We derived our target price for Celltrion by applying a target EV/EBITDA of 30x to our 12- month forward EBITDA estimate of W1.97tr.
Mirae Asset Securities
Follow
200 Views
Share
bullish
•
Celltrion Inc
•
06 Nov 2025 19:34
•
Broker
Celltrion (068270 KS/Buy)Cost Ratio Continues to Improve
Our target price for Celltrion is based on our 12-month forward EBITDA estimate of W1.87tr and a target EV/EBITDA of 27x.
Mirae Asset Securities
Follow
224 Views
Share
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.69.1
x